Chemokine CCL3

"Chemokine CCL3" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A CC chemokine with specificity for CCR1 RECEPTORS and CCR5 RECEPTORS. It is a chemoattractant for NK CELLS; MONOCYTES; and a variety of other immune cells. This chemokine is encoded by multiple genes.

Descriptor ID	D054405
MeSH Number(s)	D12.644.276.374.200.110.150 D12.644.276.374.200.600.150 D12.776.467.374.200.110.150 D12.776.467.374.200.600.150 D23.125.300.110.150 D23.125.300.600.500 D23.469.200.110.150 D23.469.200.600.150 D23.529.374.200.110.150 D23.529.374.200.600.150
Concept/Terms	Chemokine CCL3 Chemokine CCL3 CCL3, Chemokine Chemokine (C-C Motif) Ligand 3 LD78alpha Chemokine Chemokine, LD78alpha MIP-1alpha Small Inducible Cytokine A3 CCL3 Chemokine Chemokine, CCL3 Macrophage Inflammatory Protein 1-alpha Macrophage Inflammatory Protein 1 alpha Chemokine CCL3L3 Chemokine CCL3L3 CCL3L3, Chemokine CCL3L3 Chemokine Chemokine, CCL3L3 Chemokine CCL3L2 Chemokine CCL3L2 CCL3L2, Chemokine Chemokine (C-C Motif) Ligand 3-Like 2 CCL3L2 Chemokine Chemokine, CCL3L2 BB-10010 BB-10010 BB 10010 BB10010 Chemokine CCL3L1 Chemokine CCL3L1 CCL3L1, Chemokine Chemokine (C-C Motif) Ligand 3-Like 1 LD78beta Chemokine Chemokine, LD78beta CCL3L1 Chemokine Chemokine, CCL3L1

Below are MeSH descriptors whose meaning is more general than "Chemokine CCL3".

Chemicals and Drugs [D]
Amino Acids, Peptides, and Proteins [D12]
Peptides [D12.644]
Intercellular Signaling Peptides and Proteins [D12.644.276]
Cytokines [D12.644.276.374]
Chemokines [D12.644.276.374.200]
Chemokines, CC [D12.644.276.374.200.110]
Chemokine CCL3 [D12.644.276.374.200.110.150]
Macrophage Inflammatory Proteins [D12.644.276.374.200.600]
Chemokine CCL3 [D12.644.276.374.200.600.150]
Proteins [D12.776]
Intercellular Signaling Peptides and Proteins [D12.776.467]
Cytokines [D12.776.467.374]
Chemokines [D12.776.467.374.200]
Chemokines, CC [D12.776.467.374.200.110]
Chemokine CCL3 [D12.776.467.374.200.110.150]
Macrophage Inflammatory Proteins [D12.776.467.374.200.600]
Chemokine CCL3 [D12.776.467.374.200.600.150]
Biological Factors [D23]
Chemotactic Factors [D23.125]
Chemokines [D23.125.300]
Chemokines, CC [D23.125.300.110]
Chemokine CCL3 [D23.125.300.110.150]
Macrophage Inflammatory Proteins [D23.125.300.600]
Chemokine CCL3 [D23.125.300.600.500]
Inflammation Mediators [D23.469]
Chemokines [D23.469.200]
Chemokines, CC [D23.469.200.110]
Chemokine CCL3 [D23.469.200.110.150]
Macrophage Inflammatory Proteins [D23.469.200.600]
Chemokine CCL3 [D23.469.200.600.150]
Intercellular Signaling Peptides and Proteins [D23.529]
Cytokines [D23.529.374]
Chemokines [D23.529.374.200]
Chemokines, CC [D23.529.374.200.110]
Chemokine CCL3 [D23.529.374.200.110.150]
Macrophage Inflammatory Proteins [D23.529.374.200.600]
Chemokine CCL3 [D23.529.374.200.600.150]

Below are MeSH descriptors whose meaning is related to "Chemokine CCL3".

Below are MeSH descriptors whose meaning is more specific than "Chemokine CCL3".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Chemokine CCL3" by people in this website by year, and whether "Chemokine CCL3" was a major or minor topic of these publications.

Bar chart showing 9 publications over 9 distinct years, with a maximum of 1 publications in 1997 and 2002 and 2004 and 2010 and 2014 and 2016 and 2017 and 2018 and 2021

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1997	0	1	1
2002	0	1	1
2004	0	1	1
2010	1	0	1
2014	0	1	1
2016	0	1	1
2017	1	0	1
2018	0	1	1
2021	0	1	1

Below are the most recent publications written about "Chemokine CCL3" by people in Profiles.

da Silva Antunes R, Soldevila F, Pomaznoy M, Babor M, Bennett J, Tian Y, Khalil N, Qian Y, Mandava A, Scheuermann RH, Cortese M, Pulendran B, Petro CD, Gilkes AP, Purcell LA, Sette A, Peters B. A system-view of Bordetella pertussis booster vaccine responses in adults primed with whole-cell versus acellular vaccine in infancy. JCI Insight. 2021 04 08; 6(7).

View in: PubMed
Eckman EA, Pacheco-Quinto J, Herdt AR, Halperin JJ. Neuroimmunomodulators in Neuroborreliosis and Lyme Encephalopathy. Clin Infect Dis. 2018 06 18; 67(1):80-88.

View in: PubMed
Wong HR, Cvijanovich NZ, Anas N, Allen GL, Thomas NJ, Bigham MT, Weiss SL, Fitzgerald JC, Checchia PA, Meyer K, Quasney M, Hall M, Gedeit R, Freishtat RJ, Nowak J, Raj SS, Gertz S, Grunwell JR, Lindsell CJ. Improved Risk Stratification in Pediatric Septic Shock Using Both Protein and mRNA Biomarkers. PERSEVERE-XP. Am J Respir Crit Care Med. 2017 08 15; 196(4):494-501.

View in: PubMed
Wong HR, Cvijanovich NZ, Anas N, Allen GL, Thomas NJ, Bigham MT, Weiss SL, Fitzgerald J, Checchia PA, Meyer K, Quasney M, Hall M, Gedeit R, Freishtat RJ, Nowak J, Raj SS, Gertz S, Howard K, Harmon K, Lahni P, Frank E, Hart KW, Nguyen TC, Lindsell CJ. Pediatric Sepsis Biomarker Risk Model-II: Redefining the Pediatric Sepsis Biomarker Risk Model With Septic Shock Phenotype. Crit Care Med. 2016 Nov; 44(11):2010-2017.

View in: PubMed
Wong HR, Weiss SL, Giuliano JS, Wainwright MS, Cvijanovich NZ, Thomas NJ, Allen GL, Anas N, Bigham MT, Hall M, Freishtat RJ, Sen A, Meyer K, Checchia PA, Shanley TP, Nowak J, Quasney M, Chopra A, Fitzgerald JC, Gedeit R, Banschbach S, Beckman E, Lahni P, Hart K, Lindsell CJ. Testing the prognostic accuracy of the updated pediatric sepsis biomarker risk model. PLoS One. 2014; 9(1):e86242.

View in: PubMed
Louboutin JP, Chekmasova A, Marusich E, Agrawal L, Strayer DS. Role of CCR5 and its ligands in the control of vascular inflammation and leukocyte recruitment required for acute excitotoxic seizure induction and neural damage. FASEB J. 2011 Feb; 25(2):737-53.

View in: PubMed
Cordelier P, Kulkowsky JW, Ko C, Matskevitch AA, McKee HJ, Rossi JJ, Bouhamdan M, Pomerantz RJ, Kari G, Strayer DS. Protecting from R5-tropic HIV: individual and combined effectiveness of a hammerhead ribozyme and a single-chain Fv antibody that targets CCR5. Gene Ther. 2004 Nov; 11(22):1627-37.

View in: PubMed
Raychaudhuri B, Bonfield TL, Malur A, Hague K, Kavuru MS, Arroliga AC, Thomassen MJ. Circulating monocytes from patients with primary pulmonary hypertension are hyporesponsive. Clin Immunol. 2002 Aug; 104(2):191-8.

View in: PubMed
Thomassen MJ, Buhrow LT, Connors MJ, Kaneko FT, Erzurum SC, Kavuru MS. Nitric oxide inhibits inflammatory cytokine production by human alveolar macrophages. Am J Respir Cell Mol Biol. 1997 Sep; 17(3):279-83.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement